Certificados disponibles. Haga clic para acceder al área de impresión!







Invitados


Haga un clic en el nombre del invitado y vea su mini-currículo:




Invitados Internacionales

» ANDREW J. LEES 
Professor of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology
Born on Merseyside, Andrew Lees qualified in medicine at the Royal London Hospital Medical College in 1970. His neurological training was at University College London Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square. He also spent time at L’Hopital Salpetriere, Paris.
At the age of thirty-two he was appointed to the consultant staff at the National Hospitals, The Middlesex, and Whittington Hospitals and in 1987 was elected a Fellow of the Royal College of Physicians. He was later appointed Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square and was Director of the Reta Lila Weston Institute for Neurological Studies (1998-2012). He was Clinical Director of the Queen Square Brain Bank for Neurological Disorders (1985-2012) and Director of the Sara Koe PSP Research Centre (2002-2012).
He is a Visiting Professor at the University of Liverpool and has close collaborations with a number of Brazilian universities. For his contributions to Brazilian neurology he was elected an overseas member of the Academia Nacional de Medicina and the Academia Brasileira de Neurologica. He was elected as a Council member of the Academy of Medical Sciences 2012- 2015. Appointed as an Expert Adviser for the UK Government National Institute for Health and Care Excellence Centre for Guidelines (2006-2019).

Andrew has achieved international recognition for his work on Parkinson’s disease and abnormal movement disorders. He is an original member of the Highly Cited Researchers ISI Database with an h-index of 120. Founder member of the international Movement Disorder Society, he was elected President (2004-2006) and co-edited the Movement Disorders Journal between 1995 and 2003. In 2006, he was awarded the Movement Disorders Research Award by the American Academy of Neurology. In recent years he has delivered the Gowers Memorial Lecture at the National Hospital, The Inaugural Lord Brain Memorial Lecture at Barts and the Royal London Hospitals and David Marsden Memorial Lecture at the European Federation of Neurological Societies. He was the recipient of Stanley Fahn Lectureship Award, MDS Dublin 2012, and has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson‘s disease and Neurodegenerative Disorders.
In 2014, Andrew received the prestigious Jay Van Andel award for outstanding research in Parkinson’s disease. Based in Grand Rapids Michigan, the Van Andel Institute is an independent research organisation dedicated to preserving, enhancing and expanding the frontiers of medical science. In 2015, he became the recipient of the Association of British Neurologists Medal, awarded annually in recognition of outstanding contributions by British and Irish neurologists to the science and practice of neurology. He received the Bing Spear Award in 2016 for outstanding contributions towards saner drug policies, and has been awarded the Parkinson Canada’s Donald Calne Award and Lectureship for 2017.

» AVINDRA NATH
» CHRISTOPHER EARLEY 
Professor, Department of Neurology, Johns Hopkins School of Medicine
Associate Director, Sleep Disorders Center, JHBMC
Recipient of the AAN Sleep Science Award which is given in “recognition of outstanding achievements in Sleep Science Research”
Elected, Fellow of the Royal College of Physician, Ireland (FRCP(I)) in recognition of my work in Restless Legs Syndrome.

» EMILIO PERUCCA
» FRANCESC GRAUS 
Dr. Francesc Graus is the chief of service of Neurology of the Hospital Clinic in Barcelons, Spain. The area of research of Dr. Graus has been the clinical and immunological characterization of the paraneoplastic neurological syndromes. He led the panel of experts that defined for the first time strict criteria for their diagnosis. His research has been important for the confirmation of the immune hypothesis that the underlying tumor triggers and autoimmune attack to the nervous system causing the neurological dysfunction. In the last years he has been involved in the field of autoimmune encephalitis and other CNS disorders associated with antibodies against neuronal surface antigens. The research in this area led to the characterization of the anti-IgLON5 disease, an intriguing CNS disorder at the crossroad of autoimmunity and neurodegeneration.

» FRANCISCO LOPERA 
Francisco Lopera is full professor and Director of the “Grupo de Neurociencias de Antioquia” (GNA) at University or Antioquia in Medellín, Colombia.
As a Behavioral Neurologist Lopera Works at the Department of Internal Medicine, Clinical Neurology Service at Medical School of the Antioquia University, He plays an active role in assisting patients with Alzheimer’s Disease, CADASIL, Parkinson disease, Huntington disease, Mild cognitive impairment, Fronto-temporal dementia, and other forms of dementias. He also plays a role in assisting patients with ADHD, language impairment, conduct disorders, and other neuro-developmental problems. Lopera is the Principal Investigator in Alzheimer Prevention Iniciative program (API COLOMBIA) in collaboration with Banner Health Institute and Genentech/Roche.

» GUSTAVO C. ROMAN 
Prof. Román is founding director and Co-Director of the Houston Methodist Hospital Alzheimer & Dementia Center. Dr. Román was Professor of Neurology, Internal Medicine, and Geriatric Psychiatry at the University of Texas Health Science Center at San Antonio, and Neurologist at the Veterans Administration Audie L. Murphy Hospital in San Antonio, Texas, USA. Dr. Román is a medical graduate from the National University of Colombia with training in Neurology at the Salpêtrière Hospital, University of Paris, France, and at the University of Vermont, Burlington, VT, USA. Dr. Román was Interim Chairman of Neurology and Neurosurgery at Texas Tech University in Lubbock, Texas. He served as Chief of the Neuroepidemiology Branch at the prestigious US National Institutes of Health. At the NIH, he organized the international workshop that defined the criteria for Vascular Dementia for research studies (NINDS-AIREN Criteria). Dr. Román received the Commendation Medal of the US Department of Health and Human Services and the Distinguished Alumnus Medal of his Alma Mater. He is Honorary Member of the neurological societies of France, Spain, Panama, Dominican Republic, Cuba, Venezuela, and Austrian Society of Tropical Medicine. He was elected Fellow of the American Neurological Association, American Academy of Neurology, American College of Physicians, Royal Society of Medicine (London), Royal Society of Tropical Medicine (London) and the Colombian Academy of Medicine. In 2014, he was awarded the Doctor Honoris Causa from the National University of Colombia.

» HENRY HOULDEN 
My main interest is neurology and genetics. My early-career focused on major disease gene discovery with linkage analysis in Alzheimer’s disease (AD), leading to chromosome 21 and subsequently APP mutations as the first genetic cause of AD (Nature;353,344-46); the Swedish APP double mutation in AD (Nature Genetics;1,345-47) and the Tau gene (Nature;393,702-705). At UCL I have worked on common and rare disorders in neurogenetics, with significant impact resulting in the identification of genes for ataxia (Nature Genetics;39,1434-6 and Cell Rep;28;16:79-91), neuromuscular diseases (AJHG;93,976–983 and 95,590–601), spastic paraplegia (Annals Neurology;74,850-4 and Brain;139:1904-18), parkinsonian disorders and dystonia (Annals Neurology;73,546-553, Nature Genetics;46,989-93 and Brain;138:3567-80). I lead the recently established Neurology and Neurodegeneration Genomics England Clinical Interpretation Partnership (GeCIP), setup to examine all neurology genomes from the 100,000 genomes project (http://www.genomicsengland.co.uk/about-gecip/gecip-domains) and represents all rare diseases on the Genomics England board. In addition, his research and accredited diagnostic laboratory has established an open-access fibroblast/lymphoblast bank and the worldwide Synaptopathies Genetic Consortium (https://www.ucl.ac.uk/ion/synaptopathies) working on rare disease genomics. As a group we are very keen to collaborate on neurogenetic conditions

» MARIA ISABEL LEITE 
Professor of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology
Born on Merseyside, Andrew Lees qualified in medicine at the Royal London Hospital Medical College in 1970. His neurological training was at University College London Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square. He also spent time at L’Hopital Salpetriere, Paris.
At the age of thirty-two he was appointed to the consultant staff at the National Hospitals, The Middlesex, and Whittington Hospitals and in 1987 was elected a Fellow of the Royal College of Physicians. He was later appointed Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square and was Director of the Reta Lila Weston Institute for Neurological Studies (1998-2012). He was Clinical Director of the Queen Square Brain Bank for Neurological Disorders (1985-2012) and Director of the Sara Koe PSP Research Centre (2002-2012).
He is a Visiting Professor at the University of Liverpool and has close collaborations with a number of Brazilian universities. For his contributions to Brazilian neurology he was elected an overseas member of the Academia Nacional de Medicina and the Academia Brasileira de Neurologica. He was elected as a Council member of the Academy of Medical Sciences 2012- 2015. Appointed as an Expert Adviser for the UK Government National Institute for Health and Care Excellence Centre for Guidelines (2006-2019).

Andrew has achieved international recognition for his work on Parkinson’s disease and abnormal movement disorders. He is an original member of the Highly Cited Researchers ISI Database with an h-index of 120. Founder member of the international Movement Disorder Society, he was elected President (2004-2006) and co-edited the Movement Disorders Journal between 1995 and 2003. In 2006, he was awarded the Movement Disorders Research Award by the American Academy of Neurology. In recent years he has delivered the Gowers Memorial Lecture at the National Hospital, The Inaugural Lord Brain Memorial Lecture at Barts and the Royal London Hospitals and David Marsden Memorial Lecture at the European Federation of Neurological Societies. He was the recipient of Stanley Fahn Lectureship Award, MDS Dublin 2012, and has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson‘s disease and Neurodegenerative Disorders.
In 2014, Andrew received the prestigious Jay Van Andel award for outstanding research in Parkinson’s disease. Based in Grand Rapids Michigan, the Van Andel Institute is an independent research organisation dedicated to preserving, enhancing and expanding the frontiers of medical science. In 2015, he became the recipient of the Association of British Neurologists Medal, awarded annually in recognition of outstanding contributions by British and Irish neurologists to the science and practice of neurology. He received the Bing Spear Award in 2016 for outstanding contributions towards saner drug policies, and has been awarded the Parkinson Canada’s Donald Calne Award and Lectureship for 2017.

» NORMAN LATOV
» RAAD SHAKIR 
Professor, Department of Neurology, Johns Hopkins School of Medicine
Associate Director, Sleep Disorders Center, JHBMC
Recipient of the AAN Sleep Science Award which is given in “recognition of outstanding achievements in Sleep Science Research”
Elected, Fellow of the Royal College of Physician, Ireland (FRCP(I)) in recognition of my work in Restless Legs Syndrome.

» RAUL NOGUEIRA 
Dr. Nogueira completed his Neurology Residency at the Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital/ Harvard Medical School. He then completed Fellowships in Vascular and Critical Care Neurology as well as Neurointerventional Surgery at the MGH where he remained as a faculty member for five additional years. He moved to Atlanta in 2010 to help building the Marcus Stroke & Neuroscience Center at the Grady Memorial Hospital where he serves as the Director of the Neuroendovascular Service. He is a Professor of Neurology, Neurosurgery and Radiology at the Emory University School of Medicine, the Editor-in-Chief for the Interventional Neurology Journal and the Immediate Past President of the Society of Vascular and Interventional Neurology (SVIN). He has been involved in most of the mechanical thrombectomy trials. He was the Principal Investigator of the DAWN, Penumbra 3D Separator, and TREVO-2 trials and a Steering Committee member for the SWIFT, SWIFT Prime, and ARISE-II trials. He is currently the Principal Investigator for the RESILIENT and ENDOLOW trials. He has published over 250 manuscripts in peer-reviewed medical journals.

» SAMUEL WIEBE 
Dr. Francesc Graus is the chief of service of Neurology of the Hospital Clinic in Barcelons, Spain. The area of research of Dr. Graus has been the clinical and immunological characterization of the paraneoplastic neurological syndromes. He led the panel of experts that defined for the first time strict criteria for their diagnosis. His research has been important for the confirmation of the immune hypothesis that the underlying tumor triggers and autoimmune attack to the nervous system causing the neurological dysfunction. In the last years he has been involved in the field of autoimmune encephalitis and other CNS disorders associated with antibodies against neuronal surface antigens. The research in this area led to the characterization of the anti-IgLON5 disease, an intriguing CNS disorder at the crossroad of autoimmunity and neurodegeneration.

» SUSAN HERMAN 
Dr. Susan Herman is an Assistant Professor of Neurology at Harvard Medical School and an attending physician at Beth Israel Deaconess Medical Center. Dr. Herman received her undergraduate degree from Johns Hopkins University and her medical degree in 1993 from Columbia University College of Physicians and Surgeons. She completed a medicine internship, neurology residency, and fellowship in clinical neurophysiology and epilepsy at Columbia-Presbyterian Medical Center in New York. At Beth Israel Deaconess Medical Center, she directs the ICU-EEG monitoring program and the Epilepsy Monitoring Unit. Dr. Herman is board certified in Neurology, Clinical Neurophysiology, and Epilepsy. She is a member of the American Epilepsy Society and the American Academy of Neurology, is a past President of the American Clinical Neurophysiology Society, and Vice President of the National Association of Epilepsy Centers. Dr. Herman’s clinical research focuses on continuous EEG monitoring in the ICU, treatment of seizures and status epilepticus in acute brain injuries, and development of epilepsy and neurological outcome after brain injuries such as stroke and traumatic brain injury.

» VINCENZO GUIDETTI 
Prof. Román is founding director and Co-Director of the Houston Methodist Hospital Alzheimer & Dementia Center. Dr. Román was Professor of Neurology, Internal Medicine, and Geriatric Psychiatry at the University of Texas Health Science Center at San Antonio, and Neurologist at the Veterans Administration Audie L. Murphy Hospital in San Antonio, Texas, USA. Dr. Román is a medical graduate from the National University of Colombia with training in Neurology at the Salpêtrière Hospital, University of Paris, France, and at the University of Vermont, Burlington, VT, USA. Dr. Román was Interim Chairman of Neurology and Neurosurgery at Texas Tech University in Lubbock, Texas. He served as Chief of the Neuroepidemiology Branch at the prestigious US National Institutes of Health. At the NIH, he organized the international workshop that defined the criteria for Vascular Dementia for research studies (NINDS-AIREN Criteria). Dr. Román received the Commendation Medal of the US Department of Health and Human Services and the Distinguished Alumnus Medal of his Alma Mater. He is Honorary Member of the neurological societies of France, Spain, Panama, Dominican Republic, Cuba, Venezuela, and Austrian Society of Tropical Medicine. He was elected Fellow of the American Neurological Association, American Academy of Neurology, American College of Physicians, Royal Society of Medicine (London), Royal Society of Tropical Medicine (London) and the Colombian Academy of Medicine. In 2014, he was awarded the Doctor Honoris Causa from the National University of Colombia.
Dr. Román is Honorary President of the Pan American Society of Neuroepidemiology, and Honorary Professor, Universita degli Studi di Ferrara (Italy), Universidad de Antioquia (Colombia) and Universidad Nacional de Colombia. He participated in the International Affairs Committee of the American Academy of Neurology, and Chairman of the Neuroepidemiology Section. Dr Román served as elected Trustee to the Board of Directors of the World Federation of Neurology and Director of the WFN Latin American Initiative. He was Associate Editor of The Journal of the Neurological Sciences, and past Editor-in-Chief of Neuroepidemiology (2000-2007). He is editorial board member of Dementia and Geriatric Cognitive Disorders and ad-hoc reviewer for numerous journals. Dr. Román is an internationally recognized expert in Alzheimer’s disease, vascular dementia, cognitive neurology, neuroepidemiology, nutritional neurological disorders and tropical neurology.

» WERNER POEWE 
My main interest is neurology and genetics. My early-career focused on major disease gene discovery with linkage analysis in Alzheimer’s disease (AD), leading to chromosome 21 and subsequently APP mutations as the first genetic cause of AD (Nature;353,344-46); the Swedish APP double mutation in AD (Nature Genetics;1,345-47) and the Tau gene (Nature;393,702-705). At UCL I have worked on common and rare disorders in neurogenetics, with significant impact resulting in the identification of genes for ataxia (Nature Genetics;39,1434-6 and Cell Rep;28;16:79-91), neuromuscular diseases (AJHG;93,976–983 and 95,590–601), spastic paraplegia (Annals Neurology;74,850-4 and Brain;139:1904-18), parkinsonian disorders and dystonia (Annals Neurology;73,546-553, Nature Genetics;46,989-93 and Brain;138:3567-80). I lead the recently established Neurology and Neurodegeneration Genomics England Clinical Interpretation Partnership (GeCIP), setup to examine all neurology genomes from the 100,000 genomes project (http://www.genomicsengland.co.uk/about-gecip/gecip-domains) and represents all rare diseases on the Genomics England board. In addition, his research and accredited diagnostic laboratory has established an open-access fibroblast/lymphoblast bank and the worldwide Synaptopathies Genetic Consortium (https://www.ucl.ac.uk/ion/synaptopathies) working on rare disease genomics. As a group we are very keen to collaborate on neurogenetic conditions

Invitados Nacionales

Trabajos Científicos

Vea las reglas para el envío de los resúmenes y esté atento a los plazos.

SAIBA MAIS
Programación Científica

Consulte la programación completa de las conferencias y cursos disponibles.

SAIBA MAIS
Turismo y Hospedaje

¡No se preocupe, cuidaremos de todo para usted!

SAIBA MAIS

São Paulo

¡La ciudad que no para!
São Paulo, así como Brasil, se resalta por la mezcla de diferentes pueblos, que sumaron sus herencias para que hoy se forme la identidad del pueblo paulistano. Actualmente, son más de 70 países que dejaron su marca en la arquitectura, culinaria, deportes y en muchos otros aspectos de la ciudad.


Lugar del Evento

Transamerica Expo Center

El Transamerica Expo Center es un centro de convenciones y exposiciones ubicado en Santo Amaro, zona sur de São Paulo, y situado en un entorno de centros comerciales y de entretenimiento, como el shopping center Morumbi, Market Place, Cidade Jardim, el teatro Alfa y el autódromo de Interlagos. Cuenta con un área de 100.000 m², de los cuales 40.000 m² disponibles para alquiler, y 2.500 plazas para estacionamiento.


Avenida Dr. Mario Villas Boas Rodrigues, 387,
Santo Amaro - São Paulo - SP


Entidades realizadoras
Organización

55 51 3086 9100
ccmew.com


Agencia de Turismo

Patrocinador Diamante

Patrocinador Oro

Patrocinador Plata

Patrocinador Bronze